Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
To evaluate the safety and efficacy of 1% Pro-ocular topical gel administered twice daily for 12 weeks in treatment of Dry Eye Disease
100 Clinical Results associated with PharmaDax Inc.
0 Patents (Medical) associated with PharmaDax Inc.
100 Deals associated with PharmaDax Inc.
100 Translational Medicine associated with PharmaDax Inc.